logo
Plus   Neg
Share
Email

Endo: FDA Requests Further Stay Of Compounding Litigation - Quick Facts

Endo International plc (ENDP) announced that, due to the ongoing federal government shutdown, the U.S. FDA has requested a further stay of the company's ongoing litigation against the FDA for the duration of the shutdown. The litigation challenges the FDA's authorization of the bulk compounding of drugs, including vasopressin, that have not satisfied the legal requirements.

The FDA has now filed a motion, which Endo did not oppose, seeking a further stay of the suit for the period of time in which the government lacks appropriations.

For comments and feedback contact: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Oil major Exxon Mobil Corp. on Friday reported a 49 percent decline in profit for the first quarter from last year, while Chevron Corp.'s profit decreased 27 percent. The results of both companies were hurt by lower crude oil prices and weak refining margins. Exxon Mobil's results missed analysts' expectations, while Chevron's earnings beat estimates and its revenues missed expectations. Deutsche Bank AG reported Friday lower pre-tax profit in its first quarter with weak net revenues. Net profit, however, increased from last year with lower tax expenses. The German banking major, which ended merger talks with smaller rival Commerzbank AG on Thursday, trimmed its fiscal 2019 view to expect flat revenues, compared to previous estimate of slightly higher revenues. The shares were lo Comcast Corp. on Thursday reported a 14 percent increase in profit for the first quarter from last year on a double-digit growth in revenues. Adjusted earnings per share for the quarter beat analysts' expectations, while revenues missed their estimates. Total customer relationships increased by 3.6 percent to 30.7 million in the quarter and include net additions of 300,000.
Follow RTT